This is a preview of subscription content, log in via an institution to check access.
Notes
2013/2014 British pounds
Reference
Bennett H, et al. Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies. European Journal of Health Economics : 1 Nov 2016. Available from: URL: http://dx.doi.org/10.1007/s10198-016-0844-8
Rights and permissions
About this article
Cite this article
Cost effectiveness of DAAs in HCV improves with treatment rate. PharmacoEcon Outcomes News 766, 13 (2016). https://doi.org/10.1007/s40274-016-3534-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3534-y